Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
By assessing organ function, healthcare providers can confirm your body is prepared for the medication, minimizing risks and enhancing treatment results
Evidence from a large population-based cohort study
Retatrutide is the first triple agonist (GLP-1, GIP, glucagon) to reach Phase 3 clinical trials for obesity
Many patients use the medication for several months to achieve their desired weight, while others may continue long-term for maintenance
This stronger formulation boosts detoxification, accelerates brightening benefits, and supports deep cellular repair for visible and long-lasting rejuvenation
If youre ready to explore this transition, TrimRxs intake quiz can connect you with a provider who manages semaglutide-to-tirzepatide switches regularly and can build a personalized titration plan based on your treatment history
US$ 20.95
US$ 23.62
US$ 22.87
&srotate=0)
US$ 23.34
